Japan Agency for Medical Research and Development (AMED) leads the Initiative on Rare and Undiagnosed Diseases (IRUD) program. The program provides patients across Japan suffering from undiagnosed diseases with a diagnostic strategy that involves genetic analysis
View this resource Bookmark this resource
AMED – Initiative on Rare and Undiagnosed Diseases
Published by IRDiRC
Regulatory AffairsOrphan Drug Development GuidelineAgency For Medical Research and DevelopmentInitiative on Rare DiseaseGenetic Analysis